Get News Website

Discover What's Happening New in the World
Seattle, Washington, USA • 28°C
E-PAPER SUBSCRIBE
Get 1 Million Backlinks
  1. Home
  2. News
  3. Business
  4. Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production - CNBC

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production - CNBC

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production - CNBC
Business
6 minutes ago 0 Views 05 Comment 1.5k Share

Listen to this article

0%

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking the drugmaker's Foundayo, as the company tries to catch up to a lead in the space established by riva… [+2382 chars]

Share:

Annika Kim Constantino

Read Full Article View All Articles
Get 1 Million Backlinks

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected

13,977 Fans 21,798 Followers 7,999 Subscribers 19,764 Followers 31,999 Connections 5,000 Followers 9,000 Subscribers 18,000 Followers 2,500 Karma Join Chat Join Channel